Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q4 2021 Results - Earnings Call Transcript

Feb. 23, 2022 11:42 PM ETAllogene Therapeutics, Inc. (ALLO)
SA Transcripts profile picture
SA Transcripts

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET

Company Participants

Christine Cassiano - Chief Communications Officer

David Chang - President & Chief Executive Officer

Rafael Amado - Executive Vice President, Research & Development & Chief Medical Officer

Alison Moore - Chief Technical Officer

Eric Schmidt - Chief Financial Officer

Conference Call Participants

Michael Yee - Jefferies

Salveen Richter - Goldman Sachs

Tyler Van Buren - Cowen

Mark Breidenbach - Oppenheimer

Reni Benjamin - JMP Securities

Luca Issi - RBC

Asthika Goonewardene - Truist Securities

John Newman - Canaccord

Raju Prasad - William Blair

Dane Leone – Raymond James


Hello and thank you for standing by, and welcome to Allogene Therapeutics Fourth Quarter and Year End 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded.

I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.

Christine Cassiano

Thank you, operator, and welcome to all who have join the call. After the market closed today, Allogene issued a press release that provides a business update and financial results for the fourth quarter and full year 2021. This press release and today's webcast are both available on our website.

Joining me on the call today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; Dr. Eric Schmidt, Chief Financial Officer; and a new voice on our quarterly call, Dr. Alison Moore, Chief Technical Officer.

During today's call, we will be making certain forward-looking statements. These may include statements regarding the success and timing of our ongoing and

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.